首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Successful Induction of CD8 T Cell-Dependent Protection Against Malaria by Sequential Immunization with DNA and Recombinant Poxvirus of Neonatal Mice Born to Immune Mothers
【24h】

Successful Induction of CD8 T Cell-Dependent Protection Against Malaria by Sequential Immunization with DNA and Recombinant Poxvirus of Neonatal Mice Born to Immune Mothers

机译:DNA和重组痘病毒对免疫母亲的新生小鼠的顺序免疫成功诱导了针对疟疾的CD8 T细胞依赖性保护。

获取原文
获取原文并翻译 | 示例
       

摘要

In some parts of Africa,50% of deaths attributed to malaria occur in infants less than 8 mo.Thus,immunization against malaria may have to begin in the neonatal period,when neonates have maternally acquired Abs against malaria parasite proteins.Many malaria vaccines in development rely upon CD8 cells as immune effectors.Some studies indicate that neonates do not mount optimal CD8 cell responses.We report than BALB/c mice first immunized as neonates (7 days) with a Plasmodium yoelii circumsporozoite protein (PyCSP) DNA vaccine mixed with a plasmid expressing murine GM-CSF (DG) and bossted at 28 days with poxvirus expressing PyCSP were protected (93%) as well as mice immunized entirely as adults (70%).Protection was dependent on CD8 cells,and mice had excellent anti-PyCSP IFN-gamma and cytotoxic T lymphocyte responses.Mice born of mothers previously exposed to P.yoelii parasites or immunized with the vaccine were protected and had excellent T cell responses.These data support assessment of this immunization strategy in neonates/yong infants in areas in which malaria exacts its greatest toll.
机译:在非洲的某些地区,由于疟疾而导致的死亡中有50%发生在8个月以下的婴儿中。因此,当新生儿从母体获得抗疟原虫蛋白的抗体时,可能必须在新生儿期开始免疫疟疾。发育依赖于CD8细胞作为免疫效应物。一些研究表明,新生儿无法发挥最佳的CD8细胞反应。表达鼠GM-CSF(DG)并在28天后被表达PyCSP的痘病毒感染的质粒受到保护(93%)以及完全成年免疫的小鼠(70%)。保护取决于CD8细胞,小鼠具有出色的抗-PyCSPIFN-γ和细胞毒性T淋巴细胞反应。受过P.yoelii寄生虫感染或经疫苗免疫的母亲所生的小鼠受到保护,并具有出色的T细胞反应。这些数据支持评估f在疟疾危害最大的地区,这种免疫策略适用于新生儿/婴儿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号